Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.74 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.43 |
| ▸ | GALR3 | O60755 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.34 |
| ▸ | PRKCA | P17252 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propylene Glycol SCHEMBL944726 | 0.87 | TSHR (0.70) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| Alcohol SCHEMBL247964 | 0.86 | TSHR (0.78) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| Ethylene Glycol SCHEMBL1401169 | 0.86 | TSHR (0.78) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL21064874 | 0.86 | TSHR (1.00) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL19193 | 0.86 | — | — | |
| Alcohol SCHEMBL23702395 | 0.84 | TSHR (0.74) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| Alcohol SCHEMBL27846676 | 0.84 | TSHR (0.74) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| Propane SCHEMBL27531646 | 0.83 | TSHR (0.82) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| Ammonia Solution, Strong SCHEMBL5086843 | 0.83 | — | — | |
| Methyl Alcohol SCHEMBL584909 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110137564-B | Preparation method of porous solid electrolyte for lithium ion battery | 中国科学院合肥物质科学研究院 | 2021-08-10 | — | — | CN | disclosed |
| CN-105777869-B | The composition of cyclic peptide compound | 上海天伟生物制药有限公司 | 2019-09-27 | — | — | CN | disclosed |
| CN-110137564-A | A kind of porous type solid electrolyte preparation method for lithium ion battery | 中国科学院合肥物质科学研究院 | 2019-08-16 | — | — | CN | disclosed |
| CN-105777869-A | Cyclopeptide-type compound composition | 上海天伟生物制药有限公司 | 2016-07-20 | — | — | CN | disclosed |
| EP-2989080-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED 3-HYDROXYMETHYLPIPERIDINE | Reuter Chemische Apparatebau KG (DE) | 2016-03-02 | — | — | EP | disclosed |
| WO-2014173855-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED 3-HYDROXYMETHYLPIPERIDINE | REUTER CHEMISCHE APPARATEBAU KG (DE) | 2014-10-30 | — | — | WO | disclosed |
| US-7186863-B2 | Sertraline compositions | TRANSFORM PHARMACEUTICALS, INC. (US) | 2007-03-06 | — | — | US | disclosed |
| US-20050014829-A1 | Sertraline compositions | TRANSFORM PHARMACEUTICALS, INC. | 2005-01-20 | — | — | US | disclosed |
| CN-1059167-A | With 1,1-two chloro-1-fluoroethanes, methylene dichloride and methyl alcohol are the cleaning combination of main component | ATOCHEM (FR) | 1992-03-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014829-A1 | Sertraline compositions | SUCNR1, TST, SORD | TSHR 96/4885CHRM2 2003/4885CHRM4 2633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.